Great Point Partners

Type

Private equity

Status

Active

Location

Greenwich, United States

Total investments

48

Average round size

58M

Portfolio companies

45

Rounds per year

2.29

Lead investments

15

Follow on index

0.06

Exits

32

Stages of investment
Private EquityEarly Stage Venture
Areas of investment
BiotechnologyInformation TechnologyHealth CareHospitalManufacturingMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharma

Summary

Great Point Partners is the famous VC, which was founded in 2003. The main office of represented VC is situated in the Greenwich. The venture was found in North America in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight APT Pharmaceuticals, Solta Medical, Bovie Medical. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Therapeutics, Health Care.

Besides them, we counted 7 critical employees of this fund in our database.

The top activity for fund was in 2013. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. This Great Point Partners works on 36 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2015. The real fund results show that this VC is 40 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Great Point Partners, startups are often financed by Sutter Hill Ventures, SSM Partners, LiveOak Equity Partners. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Versant Ventures, Three Arch Partners. In the next rounds fund is usually obtained by Francisco Partners, Vivo Capital, Versant Ventures.

Show more

Investor highlights

Industry focus
HealthcareBiotech/Life SciencesLogisticsMedtech
Stage focus
Series CSeries DSeries FSeries E
Geo focus
AustriaBelgiumCanadaFranceGermany Show 9 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 506000000
Fund raised date
2022-09-05

Analytics

Total investments
48
Lead investments
15
Exits
32
Rounds per year
2.29
Follow on index
0.06
Investments by industry
  • Biotechnology (36)
  • Health Care (31)
  • Medical (15)
  • Therapeutics (10)
  • Pharmaceutical (9)
  • Show 21 more
Investments by region
  • United States (42)
  • France (1)
  • Canada (2)
  • Latvia (1)
  • United Kingdom (2)
Peak activity year
2024

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
46M
Group Appearance index
0.71
Avg. company exit year
11
Avg. multiplicator
0.50
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Forbes Medi-Tech 07 Jan 2004 Biotechnology, Health Care, Life Science, Nutrition, Dietary Supplements Early Stage Venture 10M United States, New Jersey

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.